This mutation occurs in NR4A2 (nuclear receptor subfamily 4 group A member 2) on Chromosome 2. Does this change lead to a known medical condition, or is it benign?
Pathogenic; Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism